| Nov 6 |
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
| Nov 5 |
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
|
| Nov 4 |
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now?
|
| Nov 4 |
Big Pharma’s Obesity Bonanza Faces New Tests
|
| Nov 3 |
Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market
|
| Nov 2 |
Amgen Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
|
| Nov 1 |
Amgen Third Quarter 2024 Earnings: EPS Beats Expectations
|
| Oct 31 |
Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight
|
| Oct 31 |
Q3 2024 Amgen Inc Earnings Call
|
| Oct 31 |
Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
|
